Conditions: Dry Eye Syndromes Keratoconjunctivitis Sicca
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 82
Healthy volunteers: no

Brief summary:
This study will evaluate the safety and efficacy of OPTIVE® MD for ocular surface integrity in symptomatic dry eye condition in absence of obvious eye-lid inflammation.

Detailed description:

Arms:
arm 1: carboxymethylcellulose 0.5% and glycerin 0.9% (OPTIVE® MD) arm 2: sodium hyaluronate 0.18% (VISMED® Multi)

Interventions: intervention 1: carboxymethylcellulose 0.5% , glycerin 0.9% (OPTIVE® MD) intervention 2: sodium hyaluronate 0.18% (VISMED® Multi)
Intervention descriptions: intervention 1: One drop in each eye three to six times daily, as needed intervention 2: One drop in each eye three to six times daily, as needed

Protocol document: